相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Elevated TNF-α is associated with pain and physical disability in mucopolysaccharidosis types I, II, and VI
Lynda E. Polgreen et al.
MOLECULAR GENETICS AND METABOLISM (2016)
A phase 1/2 study of intrathecal heparan-N-sulfatase in patients with mucopolysaccharidosis IIIA
Simon A. Jones et al.
MOLECULAR GENETICS AND METABOLISM (2016)
A novel LC-MS/MS assay for heparan sulfate screening in the cerebrospinal fluid of mucopolysaccharidosis IIIA patients
Hicham Naimy et al.
BIOANALYSIS (2016)
Delivery of therapeutic protein for prevention of neurodegenerative changes: Comparison of different CSF-delivery methods
Neil R. Marshall et al.
EXPERIMENTAL NEUROLOGY (2015)
Determination of the role of injection site on the efficacy of intra-CSF enzyme replacement therapy in MPS IIIA mice
Helen Beard et al.
MOLECULAR GENETICS AND METABOLISM (2015)
Mucopolysaccharide diseases: A complex interplay between neuroinflammation, microglial activation and adaptive immunity
Louise D. Archer et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2014)
Carotid intima-media thickness is increased in patients with treated mucopolysaccharidosis types I and II, and correlates with arterial stiffness
Raymond Y. Wang et al.
MOLECULAR GENETICS AND METABOLISM (2014)
Glycan-based biomarkers for mucopolysaccharidoses
Roger Lawrence et al.
MOLECULAR GENETICS AND METABOLISM (2014)
Reference Range of Cerebrospinal Fluid Opening Pressure in Children: Historical Overview and Current Data
Robert A. Avery
NEUROPEDIATRICS (2014)
Delivery of an enzyme-IGFII fusion protein to the mouse brain is therapeutic for mucopolysaccharidosis type IIIB
Shih-hsin Kan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Feasibility and Safety of Systemic rAAV9-hNAGLU Delivery for Treating Mucopolysaccharidosis IIIB: Toxicology, Biodistribution, and Immunological Assessments in Primates
Darren A. Murrey et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2014)
Biomarkers of bone remodeling in children with mucopolysaccharidosis types I, II, and VI
David A. Stevenson et al.
JOURNAL OF PEDIATRIC REHABILITATION MEDICINE (2014)
Osteoimmunology in mucopolysaccharidoses type I, II, VI and VII. Immunological regulation of the osteoarticular system in the course of metabolic inflammation
V. Opoka-Winiarska et al.
OSTEOARTHRITIS AND CARTILAGE (2013)
Pentosan Polysulfate: A Novel Therapy for the Mucopolysaccharidoses
Edward H. Schuchman et al.
PLOS ONE (2013)
Disease-specific non-reducing end carbohydrate biomarkers for mucopolysaccharidoses
Roger Lawrence et al.
NATURE CHEMICAL BIOLOGY (2012)
Elevated Cerebral Spinal Fluid Cytokine Levels in Boys with Cerebral Adrenoleukodystrophy Correlates with MRI Severity
Troy C. Lund et al.
PLOS ONE (2012)
Neuropathology in Mouse Models of Mucopolysaccharidosis Type I, IIIA and IIIB
Fiona L. Wilkinson et al.
PLOS ONE (2012)
Cerebrospinal Fluid Matrix Metalloproteinases Are Elevated in Cerebral Adrenoleukodystrophy and Correlate with MRI Severity and Neurologic Dysfunction
Kathryn A. Thibert et al.
PLOS ONE (2012)
Bone, joint and tooth development in mucopolysaccharidoses: Relevance to therapeutic options
E. Oussoren et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Analysis of Glycosaminoglycans in Cerebrospinal Fluid from Patients with Mucopolysaccharidoses by Isotope-Dilution Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry
Haoyue Zhang et al.
CLINICAL CHEMISTRY (2011)
Growth, final height and endocrine sequelae in a UK population of patients with Hurler syndrome (MPS1H)
Chris J. Gardner et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2011)
Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy
Paul J. Orchard et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Therapy for the mucopolysaccharidoses
Vassili Valayannopoulos et al.
RHEUMATOLOGY (2011)
Reference Range for Cerebrospinal Fluid Opening Pressure in Children
Robert A. Avery et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Involvement of the Toll-like receptor 4 pathway and use of TNF-α antagonists for treatment of the mucopolysaccharidoses
Calogera M. Simonaro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Transplant Outcomes in Mucopolysaccharidoses
Vinod K. Prasad et al.
SEMINARS IN HEMATOLOGY (2010)
Mucopolysaccharidosis I: Management and Treatment Guidelines
Joseph Muenzer et al.
PEDIATRICS (2009)
Growth and endocrine function in patients with Hurler syndrome after hematopoietic stem cell transplantation
L. E. Polgreen et al.
BONE MARROW TRANSPLANTATION (2008)
Biochemical monitoring after haemopoietic stem cell transplant for Hurler syndrome (MPSIH): implications for functional outcome after transplant in metabolic disease
H. Church et al.
BONE MARROW TRANSPLANTATION (2007)
Heparin cofactor II-thrombin complex in MPS I: A biomarker of MPS disease
Derrick R. Randall et al.
MOLECULAR GENETICS AND METABOLISM (2006)
Musculoskeletal manifestations of hurler syndrome - Long-term follow-up after bone marrow transplantation
JS Weisstein et al.
JOURNAL OF PEDIATRIC ORTHOPAEDICS (2004)
Characterization of chemokines and their receptors in the central nervous system: physiopathological implications
A Bajetto et al.
JOURNAL OF NEUROCHEMISTRY (2002)
分享论文
